Martin Steinbakk

12.8k total citations · 2 hit papers
69 papers, 4.9k citations indexed

About

Martin Steinbakk is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Martin Steinbakk has authored 69 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 18 papers in Epidemiology and 16 papers in Molecular Medicine. Recurrent topics in Martin Steinbakk's work include Antibiotic Resistance in Bacteria (16 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Pneumonia and Respiratory Infections (9 papers). Martin Steinbakk is often cited by papers focused on Antibiotic Resistance in Bacteria (16 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Pneumonia and Respiratory Infections (9 papers). Martin Steinbakk collaborates with scholars based in Norway, Sweden and United Kingdom. Martin Steinbakk's co-authors include Arnfinn Sundsfjord, Luke Moore, Philippe J. Guérin, Laura J. V. Piddock, Alison Holmes, Abhilasha Karkey, Sadie Regmi, E. Lingaas, Gunnar Kahlmeter and Inge Dale and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and PLoS ONE.

In The Last Decade

Martin Steinbakk

66 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Understanding the mechanisms and drivers of antimicrobial resistance

2015 1.7k citations Alison Holmes, Luke Moore et al. The Lancet profile →
EUCAST expert rules in antimicrobial susceptibility testing

2011 502 citations Rafael Cantón, Derek F. J. Brown et al. Clinical Microbiology and Infection profile →

Peers

Countries citing papers authored by Martin Steinbakk

Since Specialization

Citations

This map shows the geographic impact of Martin Steinbakk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Steinbakk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Steinbakk more than expected).

Fields of papers citing papers by Martin Steinbakk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Steinbakk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Steinbakk. The network helps show where Martin Steinbakk may publish in the future.

Co-authorship network of co-authors of Martin Steinbakk

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Steinbakk. A scholar is included among the top collaborators of Martin Steinbakk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Steinbakk. Martin Steinbakk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic epidemiology of Streptococcus dysgalactiae subsp. equisimilis strains causing invasive disease in Norway during 2018 2023 ·Frontiers in Microbiology ·(unknown), Christine Monceyron Jonassen, Steinar Skrede, Audun Sivertsen, (unknown), Martin Steinbakk, Oddvar Oppegaard	8
2	Livestock-Associated MRSA CC1 in Norway; Introduction to Pig Farms, Zoonotic Transmission, and Eradication 2019 ·Frontiers in Microbiology ·Petter Elstrøm, (unknown), Christina Gabrielsen, Marc Stegger, Øystein Angen, (unknown), (unknown), Anne Margrete Urdahl, Solveig Jore, Martin Steinbakk, Marianne Sunde	36
3	Travel to Asia is a strong predictor for carriage of cephalosporin resistant E. coli and Klebsiella spp. but does not explain everything; prevalence study at a Norwegian hospital 2014–2016 2018 ·Antimicrobial Resistance and Infection Control ·Laura Espenhain, Silje Bakken Jørgensen, Truls Michael Leegaard, (unknown), (unknown), Britt Nakstad, Marianne Sunde, Martin Steinbakk	7
4	Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting 2017 ·PLoS ONE ·Per Kristian Knudsen, P Brandtzæg, E. Arne Høiby, Jon Bohlin, Ørjan Samuelsen, Martin Steinbakk, Tore G. Abrahamsen, Fredrik Müller, Karianne Wiger Gammelsrud	14
5	Epidemiology of invasive group A streptococcal infections in Norway 2010–2014: A retrospective cohort study 2016 ·European Journal of Clinical Microbiology & Infectious Diseases ·Umaer Naseer, Martin Steinbakk, H Blystad, Dominique A. Caugant	54
6	Understanding the mechanisms and drivers of antimicrobial resistance breakdown → 2015 ·The Lancet ·Alison Holmes, Luke Moore, Arnfinn Sundsfjord, Martin Steinbakk, Sadie Regmi, Abhilasha Karkey, Philippe J. Guérin, Laura J. V. Piddock	1704
7	Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences 2014 ·Proceedings of the National Academy of Sciences ·Waleed Nasser, Stephen B. Beres, Randall J. Olsen, (unknown), (unknown), S. Wesley Long, Karl G. Kristinsson, Magnús Gottfreðsson, Jaana Vuopio, Kati Räisänen, Dominique A. Caugant, Martin Steinbakk, Donald E. Low, Allison McGeer, Jessica Darenberg, Birgitta Henriques‐Normark, Chris Van Beneden, Steen Hoffmann, James M. Musser	197
8	Multilocus sequence typing and ftsI sequencing: a powerful tool for surveillance of penicillin-binding protein 3-mediated beta-lactam resistance in nontypeable Haemophilus influenzae 2014 ·BMC Microbiology ·Dagfinn Skaare, Inger Lill Anthonisen, Dominique A. Caugant, Andrew Jenkins, Martin Steinbakk, Linda M. Strand, Arnfinn Sundsfjord, Yngvar Tveten, Bjørn‐Erik Kristiansen	47
9	Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7–8 years of age 2014 ·Vaccine ·Audun Aase, Tove Karin Herstad, Silje Bakken Jørgensen, Truls Michael Leegaard, Guy A. M. Berbers, Martin Steinbakk, Ingeborg S. Aaberge	12
10	Årsrapport 2011 for sykdomsprogrammet: Blod- og seksuelt overførbare infeksjoner 2012 ·Duo Research Archive (University of Oslo) ·H Blystad, Hilde Kløvstad, (unknown), (unknown), (unknown), Kathrine Stene‐Johansen, Martin Steinbakk, (unknown), (unknown)	0
11	The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach 2011 ·Clinical Microbiology and Infection ·Johan W. Mouton, D F Brown, Petra Apfalter, Rafael Cantón, Christian G. Giske, Marina Ivanova, Alasdair MacGowan, Arne C. Rodloff, C J Soussy, Martin Steinbakk, Gunnar Kahlmeter	213
12	HPV genotype distribution according to severity of cervical neoplasia 2010 ·Gynecologic Oncology ·(unknown), Ameli Tropé, A. Kathrine Lie, Christine Monceyron Jonassen, Martin Steinbakk, Mona Hansen, Morten Jacobsen, Kate Cuschieri, Anne Eskild	47
13	Comparison of broad range 16S rDNA PCR and conventional blood culture for diagnosis of sepsis in the newborn: a case control study 2009 ·BMC Pediatrics ·(unknown), Teresa Farstad, Britt Nakstad, (unknown), Martin Steinbakk	87
14	Kikhoste – et økende problem i Norge 2006 ·Tidsskrift for Den Norske Laegeforening ·Susanne Dudman, Marius Trøseid, Tom Øystein Jonassen, Martin Steinbakk	2
15	EUCAST Technical Note on tigecycline 2006 ·Clinical Microbiology and Infection ·Derek F. J. Brown, Rafael Cantón, Alasdair MacGowan, Johan W. Mouton, Arne C. Rodloff, F. W. Goldstein, Inga Odenholt, Martin Steinbakk, Pietro E. Varaldo, Waleria Hryniewicz, Gunnar Kahlmeter	73
16	Isolation of Bordetella pertussis in blood culture from a patient with multiple myeloma 2005 ·Journal of Infection ·Marius Trøseid, Tom Øystein Jonassen, Martin Steinbakk	15
17	A Norwegian nosocomial outbreak of methicillin-resistant Staphylococcus aureus resistant to fusidic acid and susceptible to other antistaphylococcal agents 1999 ·Journal of Hospital Infection ·Bjørg Marit Andersen, K. Bergh, Martin Steinbakk, Gaute Syversen, (unknown), Håvard Dalen, (unknown)	33
18	The Leucocyte Protein L1 (Calprotectin): A Putative Nonspecific Defence Factor at Epithelial Surfaces 1995 ·Advances in experimental medicine and biology ·Per Brandtzæg, T.O. Gabrielsen, Inge Dale, Fredrik Müller, Martin Steinbakk, Magne K. Fagerhol	99
19	Influence of clindamycin, administered together with or without lactobacilli, upon intestinal ecology in rats 1987 ·FEMS Microbiology Letters ·B. Carlstedt‐Duke, Livia Alm, (unknown), Ann‐Christine Midtvedt, K. E. Norin, Martin Steinbakk, Tore Midtvedt	12
20	IN VITRO ACTIVITY OF CEFTAZIDIME, CEFOTAXIME AND GENTAMICIN AGAINST 11,521 CLINICAL ISOLATES OF BACTERIA 1987 ·Acta Pathologica Microbiologica Scandinavica Series B Microbiology ·Martin Steinbakk, Tore Midtvedt, Egil Lingaas, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact